Clinical trials in Arlon

Innovative studies focusing on atrial fibrillation and stroke prevention, examining advanced anticoagulation strategies for patients following catheter ablation procedures.

• Post-ablation care optimization
• Stroke risk reduction
• Anticoagulation management

Current trials are evaluating novel therapeutic approaches including the assessment of milvexian compared to standard treatments for preventing cardioembolic events.

Comprehensive research into hormone receptor-positive breast cancer treatment, particularly focusing on elderly patients and personalized therapeutic approaches.

• Hormone therapy optimization
• Genomic-guided treatment
• Targeted therapies

Studies are exploring combination treatments using everolimus with hormone therapy for high-risk patients with ER-positive, HER2-negative breast cancer.

Advanced research utilizing genomic profiling to guide treatment decisions in cancer care, with special attention to elderly patient populations.

• Personalized treatment strategies
• Risk assessment protocols
• Treatment optimization

Current investigations focus on tailoring therapeutic approaches based on specific disease characteristics and patient profiles.